What makes our strategy meetings unique?
Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.
With senior delegation from big pharma and innovative biotech from across the East Coast, you can network with peers from different locations, all in one place.
Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.
Solutions to your Problems
We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.
Industry Researched Topics
We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.
Senior Decision Makers
The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.
Meet Our 2022 Facilitators
Our panel of facilitators play a key role in shaping the agenda for the day. Whilst we?re busy connecting with the best industry experts, take a look at facilitators at our Strategy Meeting taking place in May
Claudia Hesselmann, PhDCo-founder & CEO ARENSIA
Tatiana EidusDirector Corporate Development North America, USA Arensia
Déborah HeintzeCo-founder and Chief Marketing Officer Lunaphore Technologies
Dr. Antonio SorrentinoHead of Translational Strategy Lunaphore Technologies
Andrew JacksonU.S. Commercial Director Sengenics
Katy McGirrDirector of Global Marketing Sengenics
Laurent AudolyFounder, CEO, Chairman of the Board Parthenon Therapeutics
Vivian ChoiHead of Global Gene Therapy Research Takeda
Tirtha ChakrabortyChief Scientific Officer Vor Biopharma
Sashka DimitrievskaGlobal Therapeutic Area Head Oncology Clinical Insights AstraZeneca
Gregory FioreChief Executive Exacis Biotherapeutics
Marco GottardisVice President of Oncology Innovation Janssen Pharmaceutical Companies of Johnson & Johnson
Vijay KasturiVice President, Clinical Development/ Medical Affairs AVEO Oncology
Karuppiah KannanExecutive Director – Global Program Leader Takeda
Johanna Kaufmann, PhDExecutive Vice President Oncology Codagenix Inc.
Geoffrey HodgeChief Executive Officer Sotio
Jeffrey HumphreyMember of Board of Directors Constellation Pharmaceuticals
Mr. Punit UpadhyayaDirector Curie Therapeutics
Oscar SeguradoChief Medical Officer ASC Therapeutics
David SherrisBiotechnology / Pharmaceutical Executive Penrose Therapeutics
Reshma SinghDirector, Translational Medicine Takeda
George TetzChief Executive Officer CLS Therapeutics
See the complete agenda and facilitator line-upDownload the strategy meeting brochure for full details
Who Should Attend the Event?
Chief Executive Officers
Executive Vice Presidents
Clinical Research and Development
See Which Topics Are Discussed at the Strategy Meeting
Overcoming challenges for early phase I/O clinical trials and maximizing opportunities for biomarker discovery
Translating cancer ‘omics’ to improved outcomes
What is the next generation of ADC’s?
Radioactivity – A particularly sensitive “antenna” with excellent tissue penetration
Role of machine learning in clinical research: transforming the future of evidence generation
Cell and Gene Therapy landscape in Hematological malignancies: Next-generation innovations beyond traditional Lentiviral CAR-T
Autoantibody biomarkers for patient stratification: An approach to trial enrichment & drug repurposing SENGENICS
Funding early biotech companies in the Biden administration era with an emphasis on oncology FOR SPONSOR
Tissue Biomarkers Innovations in Immuno-Oncology LUNAPHORE
Reasons To Attend the Strategy Meeting
Evaluating current industry best practices to merge biomarkers for individual profiling
Getting a better understanding of the next-gen antibodies and clinical trials in oncology
Leveraging the role of ctDNA genotyping to monitor minimal residual disease
Tap into the full potential of NK cells and cell/gene therapy as novels modalities
Press play to hear what your colleagues had to say...
Become an official strategy meeting partnerWhatever your business needs, we can help. Get in touch for partnering opportunities
Here To Help
Want to know more? Interested in sponsoring the event? Need help registering your team? Just get in touch and a member of the team will be happy to help.